Sapphire Foods and Devyani done – next: Jubilant Pharmova Ltd.

operates in CDMO, radiopharma, and generics through global subsidiaries. ​ It benefits from outsourcing in pharma services and speciality radiopharmaceutical demand. ​ Deleveraging and portfolio simplification are current priorities. ​ Risks include regulatory risks at plants, lumpy CDMO orders, and high capex intensity.